Dr Reddy’s Laboratories has been listed on Dow Jones Sustainability Indices (DJSI) 2016 in the pharmaceuticals, biotechnology and life sciences industry group.
“The company has been recognised for its corporate sustainability leadership and is the only pharmaceutical company on the index of emerging markets,” Dr Reddy’s said in a BSE filing.
The listing was based on 22 criterion, with Dr Reddy’s receiving high scores on product quality and recall management, environmental reporting, corporate citizenship and philanthropy, it added.
“I see our inclusion in the Dow Jones Sustainability Indices as another validation of our commitment to sustainability in all aspects of our business,” Dr Reddy’s Laboratories Co-Chairman and CEO G V Prasad said.
The Dow Jones Sustainability Indices is a leading global benchmark for corporate sustainability.